Mitomycin Treatment: Uses, Dosage, Side Effects & Interactions

Summary of Key Points

Mitomycin is a chemotherapy drug used to treat various cancers, including bladder, stomach, and lung cancer. It works by slowing or stopping the growth of cancer cells. Mitomycin is typically administered by a healthcare professional, and because it may cause side effects, regular monitoring is crucial. Always consult your doctor before making any changes to your treatment plan. Our telemedicine providers are available to answer any questions you may have.

Names of Medication

US Brand Name: Mutamycin

Generic Name: Mitomycin

The generic name refers to the active ingredient in the medication and remains consistent across all brands of this drug.

Pharmacologic Category

Antineoplastic Agent

Alkylating Agent

Antibiotic, Antitumor

Mitomycin Dosage

Mitomycin is used to treat several types of cancer. The dosage and frequency depend on the specific condition being treated. Always follow your doctor’s instructions and consult them before making any changes to your dosage. You can also reach out to one of our telemedicine providers for additional guidance.

Mitomycin for Bladder Cancer

For bladder cancer, Mitomycin is typically administered intravesically (directly into the bladder) at a dose of 40 mg once weekly for 8 weeks. After the initial treatment, your doctor may recommend maintenance therapy.

Mitomycin for Stomach Cancer

For stomach cancer, Mitomycin is usually given intravenously (IV) at a dose of 20 mg/m² every 6 to 8 weeks. The duration of treatment will depend on how well your body responds to the medication.

Mitomycin for Pancreatic Cancer

For pancreatic cancer, Mitomycin is administered intravenously at a dose of 20 mg/m² every 6 to 8 weeks. The length of treatment may vary based on your response to the therapy.

Mitomycin for Colorectal Cancer

For colorectal cancer, Mitomycin is given intravenously at a dose of 20 mg/m² every 6 to 8 weeks. The duration of treatment depends on how well the cancer responds to the medication.

Mitomycin for Lung Cancer

For lung cancer, Mitomycin is administered intravenously at a dose of 20 mg/m² every 6 to 8 weeks. Your doctor will determine the appropriate length of treatment based on your individual case.

Mitomycin for Esophageal Cancer

For esophageal cancer, Mitomycin is given intravenously at a dose of 20 mg/m² every 6 to 8 weeks. The treatment duration will be determined by your healthcare provider.

Mitomycin for Breast Cancer

For breast cancer, Mitomycin is administered intravenously at a dose of 20 mg/m² every 6 to 8 weeks. The length of treatment will vary based on your response to the medication.

Mitomycin for Head and Neck Cancer

For head and neck cancer, Mitomycin is given intravenously at a dose of 20 mg/m² every 6 to 8 weeks. Your doctor will decide how long the treatment should continue.

Mitomycin for Urothelial Carcinoma

For urothelial carcinoma, Mitomycin is typically administered intravenously at a dose of 20 mg/m² every 6 to 8 weeks. The duration of treatment depends on your response to the therapy.

Mitomycin for Ocular Surface Tumors

For ocular surface tumors, Mitomycin is applied topically as an eye drop or ointment. The dosing and frequency will be determined by your eye specialist.

Dosage Forms and Strengths

Intravenous (IV) powder for solution: 5 mg, 20 mg

Intravesical (bladder) solution: 40 mg

Topical (eye) solution: 0.02% to 0.04%

Administration Instructions for Mitomycin

Mitomycin is usually administered by a healthcare professional, either intravenously (through a vein), intravesically (into the bladder), or topically (for eye conditions). Your doctor will determine the best method of administration based on your condition. It’s important to follow all instructions carefully and attend all scheduled appointments to ensure the medication is working effectively. If you have any questions about your medication, our telemedicine team is here to assist you.

Contraindications for Mitomycin

A contraindication is a specific condition where a medication should not be used because it may cause harm. For Mitomycin, several contraindications exist, including:

1. Severe bone marrow suppression: Mitomycin can further suppress bone marrow function, leading to dangerously low blood cell levels. If you already have severe bone marrow suppression, taking Mitomycin could increase your risk of infections, bleeding, and anemia.
2. Active infection: Mitomycin weakens the immune system, making it harder to fight infections. If you have an active infection, taking Mitomycin could worsen it.
3. Kidney disease: Mitomycin is processed by the kidneys. If your kidneys are not functioning properly, this medication can accumulate in your system and cause toxicity.
4. Pregnancy: Mitomycin can harm an unborn baby. It is not recommended during pregnancy unless absolutely necessary (see more details below).
5. Breastfeeding: Mitomycin can pass into breast milk and may harm a nursing baby (see more details below).

If you have any of these conditions, discuss them with your healthcare provider before starting Mitomycin. If you’re unsure, one of our telemedicine providers can help assess your risks and determine the best course of action.

Drug to Drug Interactions

Mitomycin can interact with other medications, potentially increasing side effects or reducing its effectiveness. It’s important to inform your healthcare provider about all the medications you are currently taking, including prescription drugs, over-the-counter medications, and supplements. Some known drug interactions with Mitomycin include:

1. Vincristine (Oncovin): Combining these chemotherapy drugs may increase the risk of nerve damage.
2. Cisplatin (Platinol): Using Mitomycin and Cisplatin together can raise the risk of kidney damage.
3. Live vaccines: Vaccines such as the measles, mumps, and rubella (MMR) or varicella (chickenpox) vaccines should be avoided while taking Mitomycin, as your immune system may not be strong enough to handle live viruses.
4. Warfarin (Coumadin): Mitomycin may enhance the effects of blood thinners like Warfarin, increasing the risk of bleeding.

Always consult your healthcare provider before starting or stopping any medications. Our telemedicine providers can review your medication list to help you avoid potentially harmful drug interactions with Mitomycin.

Mitomycin in Pregnancy

Is it Safe to Take Mitomycin During Pregnancy?

No, Mitomycin is not considered safe during pregnancy. It is classified as a Category D medication, meaning there is evidence of risk to the unborn baby. Mitomycin can cause serious harm to the fetus, including birth defects and miscarriage. If you are pregnant or planning to become pregnant, it’s crucial to inform your healthcare provider. They will help you weigh the risks and benefits and may recommend alternative treatments.

Mitomycin While Breastfeeding

Is it Safe to Take Mitomycin While Breastfeeding?

No, Mitomycin is not safe while breastfeeding. The drug can pass into breast milk and may pose a risk to your baby. If you are breastfeeding or planning to breastfeed, discuss this with your healthcare provider. They may advise you to stop breastfeeding or suggest a safer treatment option for both you and your baby.

Estimated Cost of Mitomycin Treatment

The cost of Mitomycin can vary depending on your location and pharmacy. Without insurance, a 30-day supply using a GoodRx coupon is estimated to cost between $1,500 and $2,000. Prices may fluctuate, so it’s a good idea to check with your pharmacy or use a GoodRx coupon to find the most affordable option for your Mitomycin treatment.

Possible Alternatives to Mitomycin

If Mitomycin is not suitable for you, there are alternative treatments available for the conditions it commonly treats. It’s important to discuss these options with your healthcare provider before making any changes to your treatment plan. Below are some alternatives based on specific cancers:

1. Bladder cancer: Alternatives include Bacillus Calmette-Guerin (BCG) therapy, surgery, or other chemotherapy agents such as Gemcitabine (Gemzar).
2. Stomach cancer: Chemotherapy options include 5-fluorouracil (5-FU) or Capecitabine (Xeloda), as well as targeted therapies like Trastuzumab (Herceptin) for HER2-positive cancers.
3. Pancreatic cancer: Alternatives include FOLFIRINOX (a combination of chemotherapy drugs) or Gemcitabine (Gemzar) with or without Abraxane (Paclitaxel).
4. Colorectal cancer: Other options include Oxaliplatin (Eloxatin) or targeted therapies such as Bevacizumab (Avastin).
5. Lung cancer: Alternatives may include targeted therapies like Erlotinib (Tarceva) or immunotherapies such as Pembrolizumab (Keytruda).
6. Esophageal cancer: Chemotherapy options include Cisplatin (Platinol) or radiation therapy.
7. Breast cancer: Alternatives include hormone therapies like Tamoxifen or targeted therapies such as Trastuzumab (Herceptin) for HER2-positive cancers.
8. Head and neck cancer: Alternatives include Cisplatin (Platinol) or radiation therapy.
9. Urothelial carcinoma: Other treatments include immunotherapy with Atezolizumab (Tecentriq) or Pembrolizumab (Keytruda).
10. Ocular surface tumors: Alternatives include surgical removal or cryotherapy (freezing the tumor).

It’s essential to discuss any changes to your treatment plan with your healthcare provider. Our telemedicine providers are available to help you explore these options and find the most appropriate treatment for your condition.

Recent Updates on Mitomycin Research

Recent research on Mitomycin has focused on improving its delivery methods and reducing side effects. One promising area of study is the development of Mitomycin-loaded nanoparticles, which are designed to deliver the drug directly to cancer cells while minimizing damage to healthy tissue. This approach has shown potential in early studies, particularly for bladder cancer. Additionally, researchers are exploring the combination of Mitomycin with newer immunotherapies to enhance its effectiveness in treating certain cancers.

Ongoing clinical trials are also investigating the use of Mitomycin alongside other chemotherapy agents or targeted therapies for cancers such as pancreatic and colorectal cancer. These studies aim to improve patient outcomes while reducing the side effects commonly associated with traditional chemotherapy.

If you’re interested in learning more about the latest research or clinical trials involving Mitomycin, our telemedicine providers can guide you through available options and discuss whether these new treatments may be suitable for you.

James Kingsley

Learn More